Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 92.64% is 155% above its 5-year average of 36.35%, near the high end of its 5-year range (0.00%–100.00%).
0.05% below its 12-month average of 92.69%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 91.22%.
GROSS MARGIN
92.64%
GROSS MARGIN AVG TTM
92.69%
GROSS MARGIN AVG 3Y
58.73%
GROSS MARGIN AVG 5Y
36.35%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-0.05%
CURRENT VS 3Y AVG
+57.75%
CURRENT VS 5Y AVG
+154.83%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
39.32%
median of 683 covered companies
CURRENT VS SECTOR MEDIAN
+135.61%
vs the sector median at left
SeaStar Medical Holding Corporation
Market Cap
$9.17M
Gross Margin
92.64%
TTM Avg
92.69%
3Y Avg
58.73%
5Y Avg
36.35%
Market Cap
$9.21M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$9.29M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$9.80M
Gross Margin
-3767.20%
TTM Avg
-1960.46%
3Y Avg
-1022.20%
5Y Avg
-664.64%
Market Cap
$8.53M
Gross Margin
18.37%
TTM Avg
19.16%
3Y Avg
20.84%
5Y Avg
23.00%
Market Cap
$8.24M
Gross Margin
-41.30%
TTM Avg
-15.77%
3Y Avg
-3.50%
5Y Avg
-3.50%
Market Cap
$10.07M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$10.18M
Gross Margin
67.30%
TTM Avg
49.28%
3Y Avg
20.15%
5Y Avg
20.34%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SeaStar Medical Holding Corporation (ICU) | $9.17M | 92.64% | 92.69% | 58.73% | 36.35% |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.29M | 0.00% | 0.00% | 0.00% | 0.00% |
| MetaVia Inc. (MTVA)vs › | $9.75M | 0.00% | 0.00% | 0.00% | 0.00% |
| Ainos, Inc. (AIMD)vs › | $9.80M | -3767.20% | -1960.46% | -1022.20% | -664.64% |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.53M | 18.37% | 19.16% | 20.84% | 23.00% |
| DataMEDS AI, Inc. (MEDS)vs › | $8.24M | -41.30% | -15.77% | -3.50% | -3.50% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.07M | 0.00% | 0.00% | 0.00% | 0.00% |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $10.18M | 67.30% | 49.28% | 20.15% | 20.34% |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.15M | 0.00% | -261.58% | -106.09% | -70.73% |
Gross Margin
92.6%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 91.22% |
| 2026-03-31 | 90.71% |
| 2025-12-31 | 97.14% |
| 2025-09-30 | 92.35% |
| 2025-06-30 | 92.01% |
| 2025-03-31 | 100.00% |
| 2024-12-31 | 100.00% |
| 2024-09-30 | 100.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
